Bleichmar Fonti & Auld LLP has initiated a class action lawsuit against Ardent Health, Inc., alleging the company misrepresented its accounts receivable collection methodology in securities filings. According to the complaint, Ardent Health represented that it conducted detailed historical collection reviews to assess receivable quality, when the company allegedly employed a simplified 180-day cliff reservation method instead. This discrepancy in accounting practices is claimed to have resulted in overstated revenue recognition.
The allegations gained prominence following Ardent Health's disclosure on November 13, 2025, which revealed a $43 million reduction in reported revenue and a corresponding $54 million increase in liability reserves. The stock declined 33% on the announcement date, reflecting investor concerns regarding the accuracy of prior financial reporting. The restatement suggests potential material weaknesses in the company's internal controls over financial reporting.
Investors who held Ardent Health securities during the relevant period have until March 9, 2026, to submit applications requesting lead plaintiff status in the litigation. The deadline represents a critical milestone for shareholders seeking to participate in the class action proceedings. Legal counsel is advising affected investors to review their transaction records and documentation of losses incurred during the period in question.